Article
Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
14 Nov 2022
Abstract excerpt
Alzheimer's disease (AD), a chronic and progressive neurodegenerative disease, is characterized by memory and cognitive impairment and by the accumulation in the brain of abnormal proteins, more precisely beta-amyloid (β-amyloid or Aβ) and Tau proteins. Studies aimed at researching pharmacological treatments against AD have focused precisely on molecules capable, in one way or another, of preventing/eliminating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
